Therefore, in all familial cancers (BRCA1-2 and BRCAX) the VEGF expression was more intensive (HIS score 5) than in sporadic cancers (HIS score 2) (p<0.0001), (Fig. 2B). This evidence concerns the gene VEGFA and hereditary cancer.